EP0957916A4 - Procedes et compositions pour traiter l'incontinence urinaire avec du (r)-clidinium enrichi par enantiomorphisme - Google Patents

Procedes et compositions pour traiter l'incontinence urinaire avec du (r)-clidinium enrichi par enantiomorphisme

Info

Publication number
EP0957916A4
EP0957916A4 EP97932349A EP97932349A EP0957916A4 EP 0957916 A4 EP0957916 A4 EP 0957916A4 EP 97932349 A EP97932349 A EP 97932349A EP 97932349 A EP97932349 A EP 97932349A EP 0957916 A4 EP0957916 A4 EP 0957916A4
Authority
EP
European Patent Office
Prior art keywords
clidinium
compositions
methods
urinary incontinence
enantiomerically enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97932349A
Other languages
German (de)
English (en)
Other versions
EP0957916A1 (fr
Inventor
Vincent L Fabiano
John R Mccullough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP0957916A1 publication Critical patent/EP0957916A1/fr
Publication of EP0957916A4 publication Critical patent/EP0957916A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97932349A 1996-07-01 1997-06-27 Procedes et compositions pour traiter l'incontinence urinaire avec du (r)-clidinium enrichi par enantiomorphisme Withdrawn EP0957916A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2073096P 1996-07-01 1996-07-01
US20730P 1996-07-01
PCT/US1997/011258 WO1998000138A1 (fr) 1996-07-01 1997-06-27 Procedes et compositions pour traiter l'incontinence urinaire avec du (r)-clidinium enrichi par enantiomorphisme

Publications (2)

Publication Number Publication Date
EP0957916A1 EP0957916A1 (fr) 1999-11-24
EP0957916A4 true EP0957916A4 (fr) 2000-02-23

Family

ID=21800231

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97932349A Withdrawn EP0957916A4 (fr) 1996-07-01 1997-06-27 Procedes et compositions pour traiter l'incontinence urinaire avec du (r)-clidinium enrichi par enantiomorphisme

Country Status (2)

Country Link
EP (1) EP0957916A4 (fr)
WO (1) WO1998000138A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482837B1 (en) * 1998-04-24 2002-11-19 University Of Rochester Antimuscarinic compounds and methods for treatment of bladder diseases
AU2004206846B2 (en) 2003-01-16 2009-05-28 University Of Rochester Quaternary antimuscarinic compounds for the treatment of bladder diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
US4644003A (en) * 1985-04-03 1987-02-17 Research Corporation 3-quinuclidinol esters, useful as antagonists of muscarinic acetylcholine receptors
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
HAURI D.: "[Incontinence of urine: Possibilities for pharmacotherapy].", MEDIZINISCHE MONATSSCHRIFT FUR PHARMAZEUTEN, (1984) 7/8 (233-239). CODEN: MMPHDB, XP000863460 *
KOPPENHOEFER B. ET AL: "Separation of enantiomers of drugs by capillary electrophoresis I..gamma.-Cyclodextrin as chiral solvating agent.", JOURNAL OF CHROMATOGRAPHY A, (1995) 717/1-2 (181-190)., XP000605057 *
KOPPENHOEFER, BERNHARD ET AL: "Separation of enantiomers of drugs by capillary electrophoresis Part 4: hydroxypropyl-gamma-cyclodextrin as chiral solvating agent", ELECTROPHORESIS (1997), 18(6), 924-930, XP000863400 *
LIN B C (REPRINT) ET AL: "SEPARATION OF DRUG ENANTIOMERS BY CAPILLARY ELECTROPHORESIS ALPHA-CYCLODEXTRIN AS CHIRAL SOLVATING AGENT", CHROMATOGRAPHIA, (JAN 1996) VOL. 42, NO. 1-2, PP. 106-110. ISSN: 0009-5893., vol. 42, no. 1/2, 1996, DALIAN INST CHEM PHYS, ZHONG SHAN RD 161, DALIAN 116012, PEOPLES R CHINA (Reprint);CHINA PHARMACEUT UNIV, NANJING 250009, PEOPLES R CHINA; UNIV TUBINGEN, INST ORGAN CHEM, D-72076 TUBINGEN, GERMANY, pages 106 - 110, XP000863359 *
LIN, BINGCHENG ET AL: "Investigation of 123 chiral drugs by cyclodextrin-modified capillary electrophoresis", LC-GC (1997), 15(1), 40, 44-46, XP000863469 *
See also references of WO9800138A1 *
YURDAKOK M ET AL: "Treatment of enuresis: a study with imipramine, amitriptyline, chlordiazepoxide- clidinium and piracetam.", TURKISH JOURNAL OF PEDIATRICS, (1986 JUL-SEP) 28 (3) 171-5., XP000863478 *

Also Published As

Publication number Publication date
WO1998000138A1 (fr) 1998-01-08
EP0957916A1 (fr) 1999-11-24

Similar Documents

Publication Publication Date Title
PL330752A1 (en) Pharmaceutical agent for treating urinary incontinence
ZA963131B (en) Use of alpha1L-agonists for treating urinary incontinence
ZA978427B (en) Method of treating urinary incontinence
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
AU4988997A (en) Compositions and methods for treating bone deficit conditions
AU8480098A (en) Apparatus and method for treating female urinary incontinence
ZA963844B (en) Seed treatment composition and method
AU5439996A (en) Compositions and methods for treating pain
HK1031174A1 (en) Compositions and methods for treating diabetes
AU2113295A (en) Novel compositions and methods for water treatment
AU9214398A (en) Compositions and methods for treating water
GB9425578D0 (en) redial treatment of urinary incontinence
EP0909172A4 (fr) PROCEDES ET COMPOSITIONS POUR TRAITER L'INCONTINENCE URINAIRE AVEC DU (R,s)-GLYCOPYRROLATE ENRICHI EN ENANTIOMERES
AU3401199A (en) Method and composition for treating psoriasis
EP0909163A4 (fr) Procedes et compositions de traitement de l'incontinence urinaire a l'aide de (s,r)-glycopyrrolate enrichi en enantiomeres
AU3909897A (en) Apparatus for treating incontinence in females
EP0759745A4 (fr) Methode et composition accroissant la fixation du calcium
AU5594398A (en) Methods and compositions for preventing and treating bone loss
EP0835092A4 (fr) Composition et traitement pour la lutte contre la calvitie
EP0909170A4 (fr) Procedes et compositions de traitement de l'incontinence urinaire a l'aide de (s)-tridihexethyle enrichi en enantiomeres
AU5791698A (en) Methods and compositions for preventing and treating bone loss
EP0957916A4 (fr) Procedes et compositions pour traiter l'incontinence urinaire avec du (r)-clidinium enrichi par enantiomorphisme
EP0938313A4 (fr) Procedes et compositions pour traiter l'incontinence urinaire avec du (s)-clidinium enrichi par enantiomorphisme
GB2318356B (en) Composition and method
HUP0104514A2 (en) The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000111

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20010316

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20011121